Constitutive activation of the aromatic hydrocarbon receptor.

Molecular and Cellular Biology
C Y Chang, A Puga

Abstract

The ligand-activated aromatic hydrocarbon receptor (AHR) dimerizes with the AHR nuclear translocator (ARNT) to form a functional complex that transactivates expression of the cytochrome P-450 CYP1A1 gene and other genes in the dioxin-inducible [Ah] gene battery. Previous work from this laboratory has shown that the activity of the CYP1A1 enzyme negatively regulates this process. To study the relationship between CYP1A1 activity and Ah receptor activation we used CYP1A1-deficient mouse hepatoma c37 cells and CYP1A1- and AHR-deficient African green monkey kidney CV-1 cells. Using gel mobility shift and luciferase reporter gene expression assays, we found that c37 cells that had not been exposed to exogenous Ah receptor ligands already contained transcriptionally active AHR-ARNT complexes, a finding that we also observed in wild-type Hepa-1 cells treated with Ellipticine, a CYP1A1 inhibitor. In CV-1 cells, transient expression of AHR and ARNT leads to high levels of AHR-ARNT-dependent luciferase gene expression even in the absence of an agonist. Using a green fluorescent protein-tagged AHR, we showed that elevated reporter gene expression correlates with constitutive nuclear localization of the AHR. Transcriptional activation of t...Continue Reading

References

Feb 1, 1979·Chemico-biological Interactions·P LescaD Mansuy
Apr 15, 1992·Biochemical and Biophysical Research Communications·M EmaY Fujii-Kuriyama
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K M BurbachC A Bradfield
Aug 31, 1992·Biochemical and Biophysical Research Communications·V VasiliouD W Nebert
Jan 1, 1989·The International Journal of Biochemistry·D W Nebert, J E Jones
Jul 1, 1989·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J B SilkworthL S Kaminsky
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P B JonesJ P Whitlock
Jan 1, 1987·Annual Review of Biochemistry·D W Nebert, F J Gonzalez
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A Fujisawa-SeharaY Fujii-Kuriyama
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Dec 8, 1995·The Journal of Biological Chemistry·B N FukunagaO Hankinson
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Oct 1, 1995·Toxicology and Applied Pharmacology·J M Peters, L M Wiley
Nov 3, 1995·The Journal of Biological Chemistry·H I SwansonC A Bradfield
Jan 1, 1995·Canadian Journal of Physiology and Pharmacology·J V GiannoneP A Harper
May 1, 1994·Toxicology and Applied Pharmacology·B D AbbottL S Birnbaum
Jun 23, 1993·Annals of the New York Academy of Sciences·D W NebertV Vasiliou
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K M DolwickC A Bradfield
Jan 1, 1996·Genes & Development·D D Isaac, D J Andrew
Oct 1, 1995·Developmental Dynamics : an Official Publication of the American Association of Anatomists·B D AbbottG H Perdew
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·H HtunG L Hager

❮ Previous
Next ❯

Citations

Apr 7, 2007·FEBS Letters·Robert BaroukiPedro M Fernandez-Salguero
Nov 29, 2011·Toxicology Letters·Min-Cong HuangJyan-Gwo J Su
Jun 23, 2009·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Carrie R FlemingRichard T Di Giulio
Jun 5, 2013·International Journal of Cancer. Journal International Du Cancer·Gennifer D GoodeSakina E Eltom
Nov 26, 2008·Biochemical Pharmacology·Kristen A Mitchell, Cornelis J Elferink
Nov 26, 2003·Biochemical Pharmacology·Barbara C SpinkDavid C Spink
Dec 18, 2004·Toxicology Letters·Y A SidorovaV V Lyakhovich
Jan 4, 2005·Biochemical Pharmacology·Alvaro PugaYing Xia
Oct 27, 2004·Chemico-biological Interactions·Linda BerganderUlf Rannug
Nov 18, 2008·Biochemical Pharmacology·Barbara Oesch-Bartlomowicz, Franz Oesch
Sep 23, 2008·Biochemical Pharmacology·Simone Kobe de Oliveira, Albert Smolenski
Aug 1, 2006·Biochemical and Biophysical Research Communications·Mary Beth GenterDaniel W Nebert
Jul 4, 2006·Journal of Molecular and Cellular Cardiology·Soichiro UsuiJunichi Sadoshima
Mar 6, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Peter GresnerWojciech Wasowicz
Dec 20, 2014·International Journal of Cancer. Journal International Du Cancer·Masaru IshidaMototsugu Oya
Dec 12, 2012·Toxicology·Chien-Chung FangJyan-Gwo Joseph Su
Jun 12, 2016·Toxicology and Applied Pharmacology·Kuo-Liang WeiJyan-Gwo Joseph Su
Sep 6, 2002·Chemico-biological Interactions·Michael S DenisonLaura Bonati
Sep 6, 2002·Chemico-biological Interactions·Timothy P DaltonHoward G Shertzer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.